2nd Oct 2015 07:04
LONDON (Alliance News) - Premaitha Health PLC on Friday said it has signed a distribution deal for the Greek market with Antisel SA to provide its IONA test to clinical laboratories in the country.
IONA is a non-invasive prenatal screening test which estimates the risk of a foetus being affected by Down's Syndrome and other serious genetic conditions.
"Antisel has an excellent reputation and distribution network within Greece and shares our mission to drive the broader uptake of NIPT so that more pregnant women can reap the benefits," said Premaitha Chief Executive Stephen Little.
"This valuable partnership will enable us to provide the IONA test to hospitals throughout the country and we look forward to working with the Antisel team to help support clinical teams in setting up their own NIPT screening service," said Little.
Shares in Premaitha were flat at 13.5 pence just after the open on Friday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Premaitha Health